4 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Retlirafusp alfa Injection: new trials by email Literature Review of Retlirafusp alfa Injection trials Research Report on Retlirafusp alfa Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJC Retlirafusp alfa, zeprumetostat, apatinib - Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Fudan University | 55 | 2026-10-01 | 2026-10-14 |
| Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer Retlirafusp alfa Injection, Famitinib, AG - Pancreatic Cancer | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Zhengzhou University | 88 | 2026-08-31 | 2026-09-11 |
| Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM SCRT, Retlirafusp alfa Injection, Bevacizumab - CRC (Colorectal Cancer) | Phase 2 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 60 | 2026-07-30 | 2026-09-22 |
| Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases Retlirafusp alfa Injection, Capecitabine, Oxaliplatin - Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | Phase 3 | Not yet recruiting | Peking University | 332 | 2026-06-26 | 2026-06-30 |
| Retlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adenocarcinoma: A Single-Arm, Phase II Study of Safety and Efficacy Retlirafusp alfa Injection - GEJ Adenocarcinoma | Not applicable | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 30 | 2026-04-01 | 2026-03-25 |
Colorectal Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Fudan University (1) · Peking University (1) · The First Affiliated Hospital of Zhengzhou University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (2)
Kaixiong Tao, MD (1) · Tao Zhang, MD (1)